EIGR logo

Eiger BioPharmaceuticals (EIGR) Interest Expense

Annual Interest Expense

$5.47 M
+$1.33 M+32.28%

December 31, 2023

Summary

Performance

1-Year Change

+32.28%

3-Year Change

+52.09%

5-Year Change

+134.69%

15-Year Change

+258.66%

EIGR Interest Expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

59.58%
EIGR annual interest expense is higher than 59.58% of companies in Healthcare sector

High & Low

All-time High

$5.47 M
EIGR annual interest expense is currently at an all-time high

3-Year Low

$3.56 M
EIGR annual interest expense is currently +53.58% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
EIGR previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
EIGR next annual earnings announcement has not yet been scheduled

OtherEIGRexpensesmetrics:

Annual Total Expenses

$87.56 M
EIGR annual total expenses is $87.56 million

Annual Operating Expenses

$87.53 M
EIGR annual total operating expenses is $87.53 million

Annual Cost Of Goods Sold

$24.00 K
EIGR annual cost of goods sold is $24.00 thousand

Annual Income Tax

$6000.00
EIGR annual income tax is $6000.00

Quarterly Interest Expense

$1.43 M
+$14.00 K+0.99%

December 31, 2023

Summary

Performance

3-Month Change

+0.99%

1-Year Change

+16.89%

3-Year Change

+56.19%

5-Year Change

+88.87%

EIGR Quarterly Interest Expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

53.78%
EIGR quarterly interest expense is higher than 53.78% of companies in Healthcare sector

High & Low

All-time High

$1.43 M
EIGR quarterly interest expense is currently at an all-time high

3-Year Low

$886.00 K
EIGR quarterly interest expense is currently +60.95% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2023
EIGR previous earnings announcement was published on Dec 31, 2023

Next Quarterly Earnings Report Date

N/A
EIGR next earnings announcement has not yet been scheduled

OtherEIGRexpensesmetrics:

Quarterly Total Expenses

$16.42 M
EIGR quarterly total expenses is $16.42 million

Quarterly Operating Expenses

$16.32 M
EIGR quarterly total operating expenses is $16.32 million

Quarterly Cost Of Goods Sold

$101.00 K
EIGR quarterly cost of goods sold is $101.00 thousand

Quarterly Income Tax

$2000.00
EIGR quarterly income tax is $2000.00

TTM Interest Expense

$5.47 M
+$206.00 K+3.92%

December 31, 2023

Summary

Performance

3-Month Change

+3.92%

1-Year Change

+32.28%

3-Year Change

+52.09%

5-Year Change

+60.48%

EIGR TTM Interest Expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

55.02%
EIGR TTM interest expense is higher than 55.02% of companies in Healthcare sector

High & Low

All-time High

$5.47 M
EIGR TTM interest expense is currently at an all-time high

3-Year Low

$3.56 M
EIGR TTM interest expense is currently +53.58% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2023
EIGR previous earnings announcement was published on Dec 31, 2023

Next Quarterly Earnings Report Date

N/A
EIGR next earnings announcement has not yet been scheduled

OtherEIGRexpensesmetrics:

Annual Total Expenses

$87.56 M
EIGR annual total expenses is $87.56 million

Annual Operating Expenses

$87.53 M
EIGR annual total operating expenses is $87.53 million

TTM Cost Of Goods Sold

$24.00 K
EIGR TTM cost of goods sold is $24.00 thousand

TTM Income Tax

$6000.00
EIGR TTM income tax is $6000.00

Interest Expense Formula

Interest Expense = Carrying Value of Debt X Effective Interest Rate

EIGR Interest Expense Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+32.3%+16.9%+32.3%
3 y3 years+52.1%+56.2%+52.1%
5 y5 years+134.7%+88.9%+60.5%

EIGR Interest Expense Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+53.6%at high+61.0%at high+53.6%
5 y5-yearat high+60.5%at high+62.0%at high+60.5%
alltimeall timeat high+9164.4%at high+173.1%at high+531.4%

Eiger BioPharmaceuticals Interest Expense History

DateAnnualQuarterlyTTM
Dec 2023
$5.47 M(+32.3%)
$1.43 M(+1.0%)
$5.47 M(+3.9%)
Sep 2023
-
$1.41 M(+5.1%)
$5.26 M(+6.5%)
Jun 2023
-
$1.34 M(+4.5%)
$4.94 M(+9.0%)
Mar 2023
-
$1.28 M(+5.3%)
$4.53 M(+9.7%)
Dec 2022
$4.13 M(+16.1%)
$1.22 M(+11.7%)
$4.13 M(+8.4%)
Sep 2022
-
$1.09 M(+16.9%)
$3.81 M(+5.5%)
Jun 2022
-
$934.00 K(+5.4%)
$3.61 M(+1.5%)
Mar 2022
-
$886.00 K(-1.6%)
$3.56 M(+0.0%)
Dec 2021
$3.56 M(-1.0%)
$900.00 K(+0.7%)
$3.56 M(-0.4%)
Sep 2021
-
$894.00 K(+1.6%)
$3.57 M(-0.3%)
Jun 2021
-
$880.00 K(-0.6%)
$3.58 M(-0.3%)
Mar 2021
-
$885.00 K(-3.1%)
$3.60 M(+0.0%)
Dec 2020
$3.59 M(+5.5%)
$913.00 K(+0.8%)
$3.59 M(+0.7%)
Sep 2020
-
$906.00 K(+1.7%)
$3.57 M(+0.6%)
Jun 2020
-
$891.00 K(+0.8%)
$3.55 M(+0.6%)
Mar 2020
-
$884.00 K(-0.5%)
$3.52 M(+3.5%)
Dec 2019
$3.41 M(+46.2%)
$888.00 K(+0.5%)
$3.41 M(+4.1%)
Sep 2019
-
$884.00 K(+1.7%)
$3.27 M(+6.6%)
Jun 2019
-
$869.00 K(+13.6%)
$3.07 M(+13.9%)
Mar 2019
-
$765.00 K(+1.3%)
$2.70 M(+15.8%)
Dec 2018
$2.33 M
$755.00 K(+10.9%)
$2.33 M(+18.3%)
Sep 2018
-
$681.00 K(+37.6%)
$1.97 M(+17.5%)
Jun 2018
-
$495.00 K(+24.4%)
$1.68 M(+7.5%)
DateAnnualQuarterlyTTM
Mar 2018
-
$398.00 K(+0.8%)
$1.56 M(+2.3%)
Dec 2017
$1.52 M(+120.9%)
$395.00 K(+1.8%)
$1.52 M(+34.4%)
Sep 2017
-
$388.00 K(+2.6%)
$1.13 M(+52.0%)
Jun 2017
-
$378.00 K(+4.1%)
$746.00 K(+102.7%)
Mar 2017
-
$363.00 K(+7160.0%)
$368.00 K(-46.7%)
Dec 2016
$690.00 K(+97.1%)
$5000.00(>+9900.0%)
$690.00 K(-154.5%)
Sep 2016
-
$0.00(0.0%)
-$1.27 M(-1683.7%)
Jun 2016
-
$0.00(-100.0%)
$80.00 K(-84.8%)
Mar 2016
-
$685.00 K(-135.1%)
$525.00 K(+50.0%)
Dec 2015
$350.00 K(-52.8%)
-$1.95 M(-244.9%)
$350.00 K(-87.1%)
Sep 2015
-
$1.35 M(+202.7%)
$2.71 M(+65.7%)
Jun 2015
-
$445.00 K(-12.7%)
$1.64 M(+37.3%)
Mar 2015
-
$510.00 K(+24.1%)
$1.19 M(+60.9%)
Dec 2014
$741.00 K(+1155.9%)
$411.00 K(+51.7%)
$741.00 K(+90.5%)
Sep 2014
-
$271.00 K(>+9900.0%)
$389.00 K(+229.7%)
Jun 2014
-
$0.00(-100.0%)
$118.00 K(0.0%)
Mar 2014
-
$59.00 K(0.0%)
$118.00 K(+100.0%)
Dec 2013
$59.00 K(-45.4%)
$59.00 K(>+9900.0%)
$59.00 K(>+9900.0%)
Sep 2013
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2013
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2013
-
$0.00
$0.00
Dec 2012
$108.00 K(-84.3%)
-
-
Dec 2011
$689.00 K(-38.7%)
-
-
Jun 2011
$1.12 M
-
-

FAQ

  • What is Eiger BioPharmaceuticals annual interest expense?
  • What is the all time high annual interest expense for Eiger BioPharmaceuticals?
  • What is Eiger BioPharmaceuticals annual interest expense year-on-year change?
  • What is Eiger BioPharmaceuticals quarterly interest expense?
  • What is the all time high quarterly interest expense for Eiger BioPharmaceuticals?
  • What is Eiger BioPharmaceuticals quarterly interest expense year-on-year change?
  • What is Eiger BioPharmaceuticals TTM interest expense?
  • What is the all time high TTM interest expense for Eiger BioPharmaceuticals?
  • What is Eiger BioPharmaceuticals TTM interest expense year-on-year change?

What is Eiger BioPharmaceuticals annual interest expense?

The current annual interest expense of EIGR is $5.47 M

What is the all time high annual interest expense for Eiger BioPharmaceuticals?

Eiger BioPharmaceuticals all-time high annual interest expense is $5.47 M

What is Eiger BioPharmaceuticals annual interest expense year-on-year change?

Over the past year, EIGR annual interest expense has changed by +$1.33 M (+32.28%)

What is Eiger BioPharmaceuticals quarterly interest expense?

The current quarterly interest expense of EIGR is $1.43 M

What is the all time high quarterly interest expense for Eiger BioPharmaceuticals?

Eiger BioPharmaceuticals all-time high quarterly interest expense is $1.43 M

What is Eiger BioPharmaceuticals quarterly interest expense year-on-year change?

Over the past year, EIGR quarterly interest expense has changed by +$206.00 K (+16.89%)

What is Eiger BioPharmaceuticals TTM interest expense?

The current TTM interest expense of EIGR is $5.47 M

What is the all time high TTM interest expense for Eiger BioPharmaceuticals?

Eiger BioPharmaceuticals all-time high TTM interest expense is $5.47 M

What is Eiger BioPharmaceuticals TTM interest expense year-on-year change?

Over the past year, EIGR TTM interest expense has changed by +$1.33 M (+32.28%)